This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House


By This Author:
Page 2 of 7443

Revance Therapeutics Announces The Appointment Of Azita Nejad As Vice President Of Quality

By GlobeNewswire

Inducement Grants Awarded Under NASDAQ Listing Rule 5635(c)(4)

04:10PM 09/22/14

PGT Completes The Acquisition Of CGI Windows & Doors

By GlobeNewswire

Strengthens Leadership Position in Growing Impact-Resistant Window and Door Market

04:05PM 09/22/14

Rand Logistics Announces Settlement Of Proxy Contest With JWEST, LLC

By GlobeNewswire

Annual Meeting to be Adjourned Until October 22, 2014

04:03PM 09/22/14

ALCO Stores Reports Second Quarter Fiscal 2015 Financial Results

By GlobeNewswire

New Company Leadership Team Identifies Turnaround Priorities and Pursues Comprehensive Recapitalization Options

04:01PM 09/22/14

Endocyte Announces Late-Breaking Abstract Presentation At The European Society For Medical Oncology (ESMO) Conference

By GlobeNewswire

- Data From Endocyte's Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR100% 2nd Line Non-Small Cell Lung Cancer (TARGET) to Be Presented -

04:01PM 09/22/14

Page 2 of 7443

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 17,172.68 -107.06 -0.62%
S&P 500 1,994.29 -16.11 -0.80%
NASDAQ 4,527.6890 -52.10 -1.14%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs